Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Covington
Baxter
Citi
Teva
Federal Trade Commission
Fuji
Deloitte
Accenture

Generated: July 19, 2018

DrugPatentWatch Database Preview

Hydrocortisone; urea - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for hydrocortisone; urea and what is the scope of hydrocortisone; urea patent protection?

Hydrocortisone; urea
is the generic ingredient in two branded drugs marketed by Bioglan and Pharmacia And Upjohn, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are sixty-four drug master file entries for hydrocortisone; urea.
Summary for hydrocortisone; urea
US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: 64
Clinical Trials: 293
DailyMed Link:hydrocortisone; urea at DailyMed

US Patents and Regulatory Information for hydrocortisone; urea

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn CALMURID HC hydrocortisone; urea CREAM;TOPICAL 083947-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bioglan ALPHADERM hydrocortisone; urea CREAM;TOPICAL 086008-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Chinese Patent Office
AstraZeneca
Harvard Business School
Julphar
UBS
Cipla
Cerilliant
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.